Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The data represent mean SEM
Lilly describes it as an investigational triple hormone receptor agonist being studied for obesity and related conditions
2008 Semaglutide start its phase II clinical trial studying and achieved good results
As with all GLP-1 medications, the most common effects are gastrointestinal - nausea, reduced appetite, or mild GI upset, usually early and dose-related
US$ 26.47
US$ 26.48
US$ 21.42
US$ 21.42
US$ 20.01
US$ 24.59
US$ 29.37
US$ 21.17
US$ 28.96
US$ 23.63
US$ 20.49
